News
Eli Lilly and Company (NYSE:LLY) is one of the most profitable growth stocks to buy according to billionaires. On August 1, ...
The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...
Redditors are complaining their long-term Mounjaro use is causing their hair to fall out in clumps. Experts claim sorting your diet out may fix the issue.
Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...
2d
GlobalData on MSNMounjaro and Zepbound fuel strong Q2 growth for Eli LillyEli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...
AN influencer says she’s been trolled for still eating her favourite pizza, smothered in chips, cheese and curry sauce.
A new study shows that weight loss medication patients can experience hunger, eat well-balanced meals, and still make ...
SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.
As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...
Mounjaro manufacturer Eli Lilly has unveiled the test results of its new oral GLP-1 medication, orforglipron. The obesity pill, which is designed to be taken daily by patients who are severely ...
Doctors at ZAVA warned that these summer staples can cause your blood sugar levels to crash and dehydrate you. This effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results